In CLL, mutations of SF3B1 have been shown to induce transcriptome-wide alterations, with an increased frequency of alternative 3′ splice site selection and functional consequences for several pathways, such as DNA damage, telomere maintenance, and methylation [10,214,215,216,217]. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.